NCT04347187

REGistry of Long-term AnTithrombotic TherApy-2

Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Atrial Fibrillation

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Detailed description

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with atrial fibrillation

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	Anticoagulants	oral anticoagulants, dual or triple antithrombotic theraphy

Timeline

• Start date: 2015-01-15
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2020-04-15
• Last updated: 2025-03-21

Locations

1 site across 1 country: Russia